Wednesday, December 25, 2019 11:43:11 AM
It is getting interesting to say the least if they get approval on an AD drug, that is more effective, then the other four drugs that are available.
They listed a lot of others diseases it might effect in their claims, but claim 0002 stated AD.
Checked on short positions which posted last night from Dec 13th. Up to 4.7M plus shorts. That is up from 4.3 some.Hope none have covered. With the current volume only 3 some days to cover.
The next cc is a must listen for any hints.
It would have been nice to get a PR on the recent Orphan Drug status approval but I guess CW doesn't think it is important enough to tell the shareholders. Without Floblu we would not have known. Thank you Floblu.
We could have had a good pop on a PR with that news. The FDA doesn't just hand those out willy nilly. Afraid to spend the money for a PR when it can have a positive impact is not how other companies do it..
Not every day one gets granted Orphan Drug Status.
At any rate I am still positive on what the company is doing.
All stay safe and thank you for the kind comments.
OT: Two more PT sessions and then I suck it up. Bad pain day yesterday and feeling good today. Go figure.
Boing X 2
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM